Entezari Morteza, Ansari Iman, Ramezani Alireza, Nikkhah Humayoun, Mohammadi Parisa, Kheiri Bahar
Negah Aref Ophthalmic Research Centre, Shahid Beheshti Medical Sciences, Tehran, Iran.
Ophthalmic Research Center, Department of Ophthalmology, Imam Hossein Medical Center, Shahid Beheshti Medical Sciences, Tehran, Iran.
J Ophthalmol. 2022 Jul 31;2022:4024603. doi: 10.1155/2022/4024603. eCollection 2022.
To compare superficial retinal vascular, choriocapillaris (CC), and choroidal thickness changes in chronic central serous chorioretinopathy (CSCR) patients after half-dose photodynamic therapy (PDT).
In this prospective interventional case series study, fifteen eyes of 14 patients with chronic CSCR undergoing half-dose PDT treatment were enrolled. All patients underwent enhanced depth imaging optical coherence tomography angiography (EDI-OCT) and optical coherence tomography angiography (OCTA) at baseline and 3 months after treatment. Best-corrected visual acuity (BCVA), superficial retinal vascular density, CC vessel density, foveal avascular zone (FAZ), central macular thickness (CMT), and choroidal thickness were compared.
Mean BCVA before and after PDT was 0.34 ± 0.26 and 0.19 ± 0.25 logMAR, respectively (=0.011). Mean FAZ before treatment was 410.21 ± 117.00 m, which increased to 433.50 ± 116.76 m (=0.253). Mean vessel density at superficial capillary plexus (SCP) was 38.93 ± 11.12 at baseline, which increased to 39.04 ± 11.43 (=0.886). Mean CC vessel density was 53.21 ± 4.14 at baseline, which significantly decreased to 51.85 ± 4.21 (=<0.001). BCVA has no significant correlation with FAZ (=0.282) and vessel density (=0.0.241) at SCP. CMT significantly decreased from 380.87 ± 41.66 at baseline to 268.20 ± 28.07 at 3 months (=0.132). We did not find any correlation between CMT and FAZ (=0.040) and vessel density (=0.686) at SCP. Mean subfoveal choroidal thickness reduced from 411 ± 171 m before treatment to 372 ± 117 m (=0.106).
PDT treatment can affect retinal and choroidal structural parameters, but we could not find any significant influence on retinal vascular parameters, including FAZ area and vessel densityonly mean CC vessel density and subfoveal choroidal thickness decreased.
比较慢性中心性浆液性脉络膜视网膜病变(CSCR)患者接受半剂量光动力疗法(PDT)后视网膜浅层血管、脉络膜毛细血管(CC)和脉络膜厚度的变化。
在这项前瞻性介入性病例系列研究中,纳入了14例接受半剂量PDT治疗的慢性CSCR患者的15只眼。所有患者在基线期和治疗后3个月均接受了增强深度成像光学相干断层扫描血管造影(EDI-OCT)和光学相干断层扫描血管造影(OCTA)检查。比较了最佳矫正视力(BCVA)、视网膜浅层血管密度、CC血管密度、黄斑无血管区(FAZ)、中心黄斑厚度(CMT)和脉络膜厚度。
PDT治疗前后的平均BCVA分别为0.34±0.26和0.19±0.25 logMAR(=0.011)。治疗前平均FAZ为410.21±117.00μm,增加至433.50±116.76μm(=0.253)。视网膜浅层毛细血管丛(SCP)的平均血管密度在基线时为38.93±11.12,增加至39.04±11.43(=0.886)。CC平均血管密度在基线时为53.21±4.14,显著降至51.85±4.21(=<0.001)。BCVA与FAZ(=0.282)和SCP处的血管密度(=0.241)无显著相关性。CMT从基线时的380.87±41.66μm显著降至3个月时的268.20±28.07μm(=0.132)。我们未发现CMT与FAZ(=0.040)和SCP处的血管密度(=0.686)之间存在任何相关性。黄斑中心凹下脉络膜平均厚度从治疗前的411±171μm降至372±117μm(=0.106)。
PDT治疗可影响视网膜和脉络膜结构参数,但我们未发现对视网膜血管参数有任何显著影响,包括FAZ面积和血管密度,仅CC平均血管密度和黄斑中心凹下脉络膜厚度降低。